Description

Gliucofaj Coated Tablets 850 mg. №30

Ingredients:

Each coated tablet contains 850 mg of Metformin Hydrochloride.

Dosage:

The usual dose is one tablet taken orally with meals, once or twice daily, or as directed by a healthcare provider.

Indications:

Gliucofaj coated tablets are indicated for the treatment of type 2 diabetes mellitus. It helps to control blood sugar levels and may prevent complications of diabetes.

Contraindications:

Do not use Gliucofaj tablets if you have severe kidney disease, metabolic acidosis, or a history of lactic acidosis. Consult a healthcare provider before starting this medication.

Directions:

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. Follow the dosage instructions provided by your doctor.

Scientific Evidence:

Studies have shown that Metformin, the active ingredient in Gliucofaj tablets, is effective in lowering blood glucose levels by decreasing hepatic glucose production and increasing insulin sensitivity. Research published in the Journal of Clinical Investigation demonstrated the beneficial effects of Metformin in improving glycemic control and reducing cardiovascular risk factors in patients with type 2 diabetes.

Additional Information:

Gliucofaj coated tablets are formulated to provide a controlled release of Metformin, allowing for better tolerability and reduced gastrointestinal side effects compared to immediate-release formulations. It is important to monitor kidney function regularly while taking this medication, as Metformin can affect renal function in some individuals.

Consult your healthcare provider for personalized advice on the use of Gliucofaj tablets and to discuss any potential drug interactions or side effects.